Belvisi, D.; Tartaglia, M.; Borriello, G.; Baione, V.; Crisafulli, S.G.; Zuccoli, V.; Leodori, G.; Ianniello, A.; Pasqua, G.; Pantano, P.;
et al. Are Neurophysiological Biomarkers Able to Discriminate Multiple Sclerosis Clinical Subtypes? Biomedicines 2022, 10, 231.
https://doi.org/10.3390/biomedicines10020231
AMA Style
Belvisi D, Tartaglia M, Borriello G, Baione V, Crisafulli SG, Zuccoli V, Leodori G, Ianniello A, Pasqua G, Pantano P,
et al. Are Neurophysiological Biomarkers Able to Discriminate Multiple Sclerosis Clinical Subtypes? Biomedicines. 2022; 10(2):231.
https://doi.org/10.3390/biomedicines10020231
Chicago/Turabian Style
Belvisi, Daniele, Matteo Tartaglia, Giovanna Borriello, Viola Baione, Sebastiano Giuseppe Crisafulli, Valeria Zuccoli, Giorgio Leodori, Antonio Ianniello, Gabriele Pasqua, Patrizia Pantano,
and et al. 2022. "Are Neurophysiological Biomarkers Able to Discriminate Multiple Sclerosis Clinical Subtypes?" Biomedicines 10, no. 2: 231.
https://doi.org/10.3390/biomedicines10020231
APA Style
Belvisi, D., Tartaglia, M., Borriello, G., Baione, V., Crisafulli, S. G., Zuccoli, V., Leodori, G., Ianniello, A., Pasqua, G., Pantano, P., Berardelli, A., Pozzilli, C., & Conte, A.
(2022). Are Neurophysiological Biomarkers Able to Discriminate Multiple Sclerosis Clinical Subtypes? Biomedicines, 10(2), 231.
https://doi.org/10.3390/biomedicines10020231